Tumor Necrosis Factor and Interleukin-1β Upregulate NRP2 Expression and Promote SARS-CoV-2 Proliferation
Authors:
- Michinori IshitokuMIMichinori Ishitoku
- Sho MokudaSMSho Mokuda
- Kei ArakiKAKei Araki
- Hirofumi WatanabeHWHirofumi Watanabe
- Hiroki KohnoHKHiroki Kohno
- Tomohiro SugimotoTSTomohiro Sugimoto
- Yusuke YoshidaYYYusuke Yoshida
- Takemasa SakaguchiTSTakemasa Sakaguchi
- Junya MasumotoJMJunya Masumoto
- Shintaro HirataSHShintaro Hirata
- Eiji SugiyamaESEiji Sugiyama
Open Access
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), utilizes the host receptor angiotensin-converting enzyme 2 (ACE2) and the auxiliary receptor Neuropilin-1 (NRP1) to enter host cells. NRP1 has another isoform, NRP2, whose function in COVID-19 has seldom been reported. In addition, although patients with severe cases of COVID-19 often exhibit increased levels of proinflammatory cytokines, the relationship between these cytokines and SARS-CoV-2 proliferation remains unknown. The aim of this study is to clarify the roles of proinflammatory cytokines in Neuropilin expressions and in SARS-CoV-2 infection. To identify the expression patterns of NRP under inflamed and noninflamed conditions, next-generation sequencing (RNA-seq), immunohistochemistry, quantitative real-time PCR, and Western blotting were performed using primary cultured fibroblast-like synoviocytes, MH7A (immortalized cell line of human rheumatoid fibroblast-like synoviocytes), immortalized MRC5 (human embryonic lung fibroblast), and synovial tissues. To measure viral proliferative capacity, SARS-CoV-2 infection experiments were also performed. NRP2 was upregulated in inflamed tissues. Cytokine-stimulated human fibroblast cell lines, such as MH7A and immortalized MRC5, revealed that NRP2 expression increased with co-stimulation of tumor necrosis factor α (TNFα) and interleukin-1 beta (IL-1β) and was suppressed with anti-TNFα antibody alone. TNFα and IL-1β promoted SARS-CoV-2 proliferation and Spike protein binding. The viral proliferation coincided with the expression of NRP2, which was modulated through plasmid transfections. Our results revealed that proinflammatory cytokines, including TNFα, contribute to NRP2 upregulation and SARS-CoV-2 proliferation in host human cells.Keywords
Funding Information
- JSPS KAKENHI (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- AMED Research Grants for COVID-19 (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Mitsubishi Foundation (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Takeda Science Foundation (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Japanese Respiratory Foundation (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Japan College of Rheumatology Grant for Promoting Research for Early RA (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Nakatomi Foundation (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Okinaka Memorial Institute for Medical Research (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- TSUCHIYA MEMORIAL MEDICAL FOUNDATION (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
- Rotary Club of Hiroshima (17H04656, 19K18499, 22K08599, JP21fk0108558, JP21fk0108550)
This publication has 38 references indexed in Scilit:
- CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosisArthritis Research & Therapy, 2015
- Immunological functions of the neuropilins and plexins as receptors for semaphorinsNature Reviews Immunology, 2013
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trialGut, 2011
- Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entryProceedings of the National Academy of Sciences, 2008
- TNF-α Induces MMP2 Gelatinase Activity and MT1-MMP Expression in an In Vitro Model of Nucleus Pulposus Tissue DegenerationSpine, 2008
- Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trialArthritis & Rheumatism, 2007
- Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2006
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedAnnals of the Rheumatic Diseases, 2004
- Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1Journal of Cellular Biochemistry, 2002